CapitalNumbers Infotech Secures ₹ 2.46 Crore New Order for AI Project in Healthcare

CapitalNumbers Infotech Secures ₹ 2.46 Crore New Order for AI Project in Healthcare

CapitalNumbers Infotech Secures ₹ 2.46 Crore New Order for AI Project in Healthcare​

CapitalNumbers Infotech Ltd has secured a new order worth ₹ 2.46 Crore, focusing on an Artificial Intelligence (AI) project within the healthcare domain. The contract was awarded by an international entity based in the UK.

The agreement details highlight the nature and scope of the work, which is categorized as a Time and Materials (T&M) contract. This assignment is set to be executed over a period of six months.

The transaction involves a UK Based Entity, indicating that CapitalNumbers Infotech Ltd has successfully secured international business. The project falls within the specialized field of AI applications tailored for the healthcare sector.

Key details regarding the newly acquired order are presented below:

DetailSpecification
Order ValueINR 2.46 crore
Client OriginUK Based Entity (International)
Project NatureAI Project in Healthcare domain
Contract TypeTime and Materials (T&M) contract
Execution Timeline6 months

Stock Price Movement​

Capitalnumbers Infotech Ltd closed on Wednesday trading down after setting at ₹108.33, reflecting a 3.10% decline in post-market activity. The shares explored an intraday range during the session, reaching highs of ₹113.00 before settling near the low of ₹108.00.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:
Back
Top